Recent Finacing
Recent Raise
Avelas Biosciences develops the Avelas Cancer Illuminator (AVB-620), a protease-activated fluorescent peptide and imaging system that provides real-time intraoperative tumor and metastatic lymph node visualization during cancer surgery.
